WELCOME TO

Specialist Communications for Life Sciences
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.

Our
Services
PR & Media
Strategic support to drive communications programmes and build visibility
Marketing
Effectively promote products and services to generate leads
Design & Branding
Elevate company image with bespoke design services for websites and corporate materials
Investor Relations
Strengthen relationships with investors through targeted outreach

The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
EVENTS
-
Society for Neuroscience Annual Meeting 2026
-
London Life Sciences Week 2026
-
PEGS Europe 2026
-
Jefferies Global Healthcare Conference London
Calla Lily Clinical Care awarded Innovate UK grant to expand Callavid platform for vaginal microbiome health
£700k Growth Catalyst award supports adaptation of Callavid intravaginal drug delivery platform for live biotherapeutic products and probiotics Programme addresses pressing need for new approaches to vaginal dysbiosis conditions and [...]
Nuclera and University of Cambridge researchers demonstrate rapid structural analysis of challenging drug target
Collaboration combines cell-free protein synthesis, proprietary nanodisc technology and cryo-electron microscopy (cryo-EM) to enable high-resolution structural analysis of a G protein-coupled receptor (GPCR) Researchers achieved a 3.38 Å cryo-EM structure, [...]
Enterprise Therapeutics granted EMA orphan medicinal product designation for novel cystic fibrosis therapy, ETD001
Investigational inhaled ENaC blocker developed to treat people with cystic fibrosis not benefitting from CFTR modulators Positive opinion recognises potential of ETD001 in treating rare and severe disease Decision follows [...]
























